Ma Z - Search Results

1

Platelet integrin αIIbβ3: signal transduction, regulation, and its therapeutic targeting.

Huang J, Li X, Shi X, Zhu M, Wang J, Huang S, Huang X, Wang H, Li L, Deng H, Zhou Y, Mao J, Long Z, Ma Z, Ye W, Pan J, Xi X, Jin J. Huang J, et al. Among authors: ma z. J Hematol Oncol. 2019 Mar 7;12(1):26. doi: 10.1186/s13045-019-0709-6. J Hematol Oncol. 2019. PMID: 30845955 Free PMC article. Review.

2

Impact of Chemotherapy Delay on Overall Survival for AML with IDH1/2 Mutations: A Study in Adult Chinese Patients.

Wang JH, Guo Q, Ma ZX, Ma QL, Yu MX, Yin XF, Lu SS, Xie HQ, Jiang YH, Shen D, Ma LY, Shi H, Yu WJ, Lou YJ, Li Y, Yang M, Xu GX, Mao LP, Li JH, Wang HP, Wang DM, Wei JY, Tong HY, Huang J, Jin J. Wang JH, et al. PLoS One. 2015 Oct 14;10(10):e0140622. doi: 10.1371/journal.pone.0140622. eCollection 2015. PLoS One. 2015. PMID: 26466372 Free PMC article.

3

Incidence of Second Malignancies of Chronic Myeloid Leukemia During Treatment With Tyrosine Kinase Inhibitors.

Yin XF, Wang JH, Li X, Yu MX, Ma ZX, Jin J. Yin XF, et al. Clin Lymphoma Myeloma Leuk. 2016 Oct;16(10):577-581. doi: 10.1016/j.clml.2016.06.010. Epub 2016 Jun 8. Clin Lymphoma Myeloma Leuk. 2016. PMID: 27397576

4

Prognostic impact of MYH9 expression on patients with acute myeloid leukemia.

Yu M, Wang J, Zhu Z, Hu C, Ma Q, Li X, Yin X, Huang J, Zhang T, Ma Z, Zhou Y, Li C, Chen F, Chen J, Wang Y, Pan H, Wang D, Jin J. Yu M, et al. Among authors: ma q, ma z. Oncotarget. 2017 Jan 3;8(1):156-163. doi: 10.18632/oncotarget.10613. Oncotarget. 2017. PMID: 27437869 Free PMC article.

5

The combination effect of homoharringtonine and ibrutinib on FLT3-ITD mutant acute myeloid leukemia.

Li X, Yin X, Wang H, Huang J, Yu M, Ma Z, Li C, Zhou Y, Yan X, Huang S, Jin J. Li X, et al. Among authors: ma z. Oncotarget. 2017 Feb 21;8(8):12764-12774. doi: 10.18632/oncotarget.14463. Oncotarget. 2017. PMID: 28061447 Free PMC article.

6

Chidamide in FLT3-ITD positive acute myeloid leukemia and the synergistic effect in combination with cytarabine.

Li X, Yan X, Guo W, Huang X, Huang J, Yu M, Ma Z, Xu Y, Huang S, Li C, Zhou Y, Jin J. Li X, et al. Among authors: ma z. Biomed Pharmacother. 2017 Jun;90:699-704. doi: 10.1016/j.biopha.2017.04.037. Epub 2017 Apr 15. Biomed Pharmacother. 2017. PMID: 28419965

7

Prognostic significance of huntingtin interacting protein 1 expression on patients with acute myeloid leukemia.

Wang J, Yu M, Guo Q, Ma Q, Hu C, Ma Z, Yin X, Li X, Wang Y, Pan H, Wang D, Huang J, Meng H, Tong H, Qian W, Jin J. Wang J, et al. Among authors: ma q, ma z. Sci Rep. 2017 Apr 28;7:45960. doi: 10.1038/srep45960. Sci Rep. 2017. PMID: 28452374 Free PMC article.

8

Prognostic utility of six mutated genes for older patients with acute myeloid leukemia.

Wang J, Ma Z, Wang Q, Guo Q, Huang J, Yu W, Wang H, Huang J, Washington Shao Y, Chen S, Jin J. Wang J, et al. Among authors: ma z. Int J Cancer. 2018 Apr 15;142(8):1664-1670. doi: 10.1002/ijc.31178. Epub 2017 Dec 14. Int J Cancer. 2018. PMID: 29193057 Free article.

9

Promising efficacy of novel BTK inhibitor AC0010 in mantle cell lymphoma.

Yan X, Zhou Y, Huang S, Li X, Yu M, Huang J, Wang J, Ma Z, Jin J, Pan J, Li C, Li F, Jin J. Yan X, et al. Among authors: ma z. J Cancer Res Clin Oncol. 2018 Apr;144(4):697-706. doi: 10.1007/s00432-017-2570-8. Epub 2018 Feb 1. J Cancer Res Clin Oncol. 2018. PMID: 29392403

10

High Expression of TET1 Predicts Poor Survival in Cytogenetically Normal Acute Myeloid Leukemia From Two Cohorts.

Wang J, Li F, Ma Z, Yu M, Guo Q, Huang J, Yu W, Wang Y, Jin J. Wang J, et al. Among authors: ma z. EBioMedicine. 2018 Feb;28:90-96. doi: 10.1016/j.ebiom.2018.01.031. Epub 2018 Jan 31. EBioMedicine. 2018. PMID: 29402726 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14,482 results

Search Page